GRN
Showing 1 - 25 of 68
Frontotemporal Dementia, FTD, FTD-GRN Trial in Poland, Spain (Intrathalamic AAV.PGRN administration, Intrathalamic AVB-101)
Recruiting
- Frontotemporal Dementia
- +3 more
- Intrathalamic AAV.PGRN administration
- Intrathalamic AVB-101
-
Katowice, Poland
- +3 more
Oct 6, 2023
Primary Myelofibrosis, Secondary Myelofibrosis, Myeloid Malignancies Trial in Rochester (Imetelstat)
Completed
- Primary Myelofibrosis
- +2 more
-
Rochester, Minnesota(unnamed)
Aug 24, 2021
Prestige Pilot - Phoenix Atherectomy and Stellarex DCB Clinical
Active, not recruiting
- Peripheral Artery Disease (PAD)
-
Arnsberg, Germany
- +4 more
Mar 29, 2022
Myocarditis and Cardiomyopathy Trial in Mannheim
Recruiting
- Myocarditis and Cardiomyopathy
-
Mannheim, Baden Württemberg, GermanyTheresienkrankenhaus
Mar 3, 2022
Frontotemporal Dementia Trial in Merthyr Tydfil (DNL593, Placebo)
Recruiting
- Frontotemporal Dementia
- DNL593
- Placebo
-
Merthyr Tydfil, Wales, United KingdomClinical Site
Feb 26, 2022
SIGNATURE Study : DCB (Legflow) vs POBA in Fempop Arteries
Recruiting
- Peripheral Arterial Disease
- +2 more
-
Berlin, Germany
- +5 more
Aug 10, 2022
MDS, Acute Myeloid Leukemia Trial in Australia, France, Germany (Imetelstat)
Not yet recruiting
- Myelodysplastic Syndromes
- Acute Myeloid Leukemia
-
Adelaide, Australia
- +11 more
Oct 13, 2022
Peripheral Arterial Disease Trial in Worldwide (Duplex Ultrasound (DUS), IVUS with Intraarterial pressure measurement (IAP) if
Active, not recruiting
- Peripheral Arterial Disease
- Duplex Ultrasound (DUS)
- IVUS with Intraarterial pressure measurement (IAP) if needed
-
Perth, Western Australia, Australia
- +14 more
Aug 24, 2022
Neurofilament Surveillance Project (NSP)
Recruiting
- Frontotemporal Dementia
- +2 more
-
San Francisco, California
- +7 more
Feb 2, 2022
Genetic Frontotemporal Dementia Initiative for Neurodevelopment
Recruiting
- Frontotemporal Dementia
- Family Members
-
London, Ontario, CanadaWestern University
Mar 23, 2023
Healthy, Frontotemporal Dementia Trial in Canada, United Kingdom, United States (AL001, Placebo)
Completed
- Healthy
- Frontotemporal Dementia
- AL001
- Placebo
-
Birmingham, Alabama
- +7 more
Jul 23, 2020
Frontotemporal Dementia, GRN Related Frontotemporal Dementia Trial in Brescia (Anodal transcranial direct current stimulation,
Completed
- Frontotemporal Dementia
- GRN Related Frontotemporal Dementia
- Anodal transcranial direct current stimulation
- Sham transcranial direct current stimulation
-
Brescia, ItalyAzienda Ospedaliera Spedali Civili di Brescia
Mar 1, 2020
Development of Targeted RNA-Seq for Amyotrophic Lateral
Not yet recruiting
- Amyotrophic Lateral Sclerosis
- RNA sequencing
-
Bordeaux, France
- +6 more
Oct 9, 2023
A Study of a Telemedicine Program for Older Adults With Cancer
Recruiting
- Cancer
- Tele-Geriatric Oncology program
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 27, 2023
Voices Of Individuals: Challenges and Experiences Of bvFTD
Enrolling by invitation
- Frontotemporal Dementia
- +3 more
- Telephone Interview
-
Baltimore, Maryland
- +2 more
Jan 10, 2023
Frontotemporal Lobar Degeneration, Alzheimer, Cognitively Normal Trial in Philadelphia ([18F]PI-2620)
Not yet recruiting
- Frontotemporal Lobar Degeneration
- +2 more
-
Philadelphia, PennsylvaniaPerelman Center for Advance Medicine
Jul 13, 2022
Myelofibrosis Trial in Worldwide (Imetelstat, Best Available Therapy (BAT))
Recruiting
- Myelofibrosis
- Imetelstat
- Best Available Therapy (BAT)
-
La Jolla, California
- +165 more
Aug 19, 2022
Wound Healing Disorder, Impaired Wound Healing, Abdominal Wound Healing Disorder Trial in Belgium, Germany (Vacuum Assisted
Completed
- Wound Healing Disorder
- +4 more
- Vacuum Assisted Closure®
- Standard conventional wound therapy
-
Brussel, Belgium
- +14 more
Jun 24, 2020
Healthy Lifestyle Trial in Medellín (Creatine Monohydrate, Placebo, Creatine Hydrochloride)
Completed
- Healthy Lifestyle
- Creatine Monohydrate
- +2 more
-
Medellín, Antioquia, ColombiaINDEPORTES Antioquia
Jan 15, 2023
Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe
Active, not recruiting
- Hypercholesterolemia
- Mixed Dyslipidemia
- Bempedoic acid and/or its fixed-dose combination with ezetimibe
-
Aue, Germany
- +126 more
May 9, 2022
NSCLC (NSCLC) With Brain Metastases Trial in Canada, United States (GRN1005)
Terminated
- Non-small Cell Lung Cancer (NSCLC) With Brain Metastases
-
La Jolla, California
- +9 more
Jan 8, 2019